Abstract
PurposeThe increase in the prevalence "long-term cancer survivor” (LCS) patients is expected to increase the cost of LCS care. The aim of this study was to obtain information that would allow to optimise the current model of health management in Spain to adapt it to one of efficient LCS patient care.MethodsThis qualitative study was carried out using Delphi methodology. An advisory committee defined the criteria for participation, select the panel of experts, prepare the questionnaire, interpret the results and draft the final report.Results232 people took part in the study (48 oncologists). Absolute consensus was reached in three of the proposed sections: oncological epidemiology, training of health professionals and ICT functions.ConclusionThe role of primary care in the clinical management of LCS patients needs to be upgraded, coordination with the oncologist and hospital care is essential. The funding model needs to be adapted to determine the funding conditions for new drugs and technologies.
Highlights
Improvements in cancer screening, diagnosis, and treatments [1] have resulted in an increase in the "long-term cancer survivor” (LCS) population [2, 3]
In the US, where half of patients diagnosed with cancer survive at least 10 years [2], databases are available to facilitate the study of LCS patients [7], as well as specific programmes for their care and follow-up [8]
More than 80% of respondents predicted that resource constraints will affect the selection of therapies for certain types of LCS patients
Summary
Improvements in cancer screening, diagnosis, and treatments [1] have resulted in an increase in the "long-term cancer survivor” (LCS) population [2, 3]. These patients have unique needs and an increased risk of experiencing certain medical and psychosocial problems in their lifetime [4], many of which may appear at a later stage [5]. In the US, where half of patients diagnosed with cancer survive at least 10 years [2], databases are available to facilitate the study of LCS patients [7], as well as specific programmes for their care and follow-up [8]. In Italy, a 3% increase in the annual cancer survival rate has recently been reported [10]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
